R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 구조식 이미지
카스 번호:
922711-75-9
상품명:
R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
동의어(영문):
R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate;R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate;(R)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'- binaphthyl-2,2'-diyl Hydrogen Phosphate,99%e.e.;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-4-Hydroxy-2,6-di(naphthalen-2-yl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-4-Hydroxy-2,6-di(naphthalen-2-yl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-2-naphthalenyl-, 4-oxide, (11bR)-;(11BR)-8,9,10,11,12,13,14,15-OCTAHYDRO-4-HYDROXY-2,6-DI-2-NAPHTHALENYL-4-OXIDE-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN,98%,(99%EE)
CBNumber:
CB52552403
분자식:
C40H33O4P
포뮬러 무게:
608.66
MOL 파일:
922711-75-9.mol

R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 속성

녹는점
350 °C (decomp)
밀도
1.38±0.1 g/cm3(Predicted)
산도 계수 (pKa)
1.17±0.20(Predicted)
물리적 상태
가루
색상
흰색에서 밝은 노란색
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H302 삼키면 유해함 급성 독성 물질 - 경구 구분 4 경고 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 호흡 자극성을 일으킬 수 있음 특정 표적장기 독성 - 1회 노출;호흡기계 자극 구분 3 경고 GHS hazard pictograms
예방조치문구:
P261 분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.
P305+P351+P338 눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.

R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate C화학적 특성, 용도, 생산

R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 준비 용품 및 원자재

원자재

준비 용품


R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 공급 업체

글로벌( 26)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com China 15932 58
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Daicel Chiral Technologies (China)CO.,LTD 021-50460086-9 15921403865
han_yajun@dctc.daicel.com China 6854 65
Tianjin Derchemist Science & Technology Co., Ltd. 22-58627059 13920586291
zdcomcon@126.com China 2918 50
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 41438 60
Shanghai Chiral bio-compound co., Ltd. 021-5068 3667/17749785980/1029026415; 17749785980
1029026415@qq.com China 2790 58
Zhengzhou Huiju Chemical Co., Ltd. 0371-55900031 18137872243
2853979815@qq.com China 10014 55
LaaJoo 021-60702684 18516024827
huang.jiayi@sinocompound.com China 2654 58
Greenherbs Science and Technology Development Co., Ltd. 010-61136123
pub02@greenherbs.com.cn China 4049 58

R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 관련 검색:

(S)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate (11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin S- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(1-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R-4-oxide-4-hydroxy-2,6-di-1-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(1-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol R-3,3'-bis(2,4,6-triMethylphenyl)-1,1'-Binaphthalene]-2,2'-diol (1R)-3,3μ-Bis[2,4,6-tris(1-methylethyl)phenyl]-1,1μ-binaphthalene-2,2μ-diol R- 4-oxide-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis([1,1'-biphenyl]-4-yl)-1,1'-Binaphthalene]-2,2'-diol R-4-oxide-4-hydroxy-2,6-bis(2,4,6-triMethylphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol R-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
Copyright 2019 © ChemicalBook. All rights reserved